Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in the Netherlands / NCT06792227
Enrolling by invitation Not applicable

Family-Based Treatment at Home in Adolescents With Eating Disorders and Co-occurring Mental Health Conditions

NCT06792227 · tracked via the Priya Life Science Netherlands tracker
Sponsor
Karakter Kinder- en Jeugdpsychiatrie
Phase
Not applicable
Started
2023-11-01
Last updated
2025-01-24

Condition(s) studied

Eating DisordersAnorexia NervosaEating Disorder Not Otherwise Specified

Investigational drug(s) / intervention(s)

FBT-H

FBT-H: FBT is a structured treatment lasting 6-12 months, typically in an outpatient setting, with weekly sessions that gradually decrease in frequency over time (Lock \& Le Grange, 2015). It empowers parents to manage their child's recovery from the ED. The first phase focuses on weight restoration, with parents responsible for all eating decisions and restricting physical activity to reduce ED's influence. In the second phase, eating responsibility gradually shifts back to the adolescent. The final phase supports healthy adolescent development as ED symptoms subside. The FBT-H adapts FBT to a home setting, with treatment led by family counselors and psychologists as part of a multidisciplinary team, including therapists, psychologists, a psychiatrist and a nurse specialist.

Study summary

The significant impact of eating disorders on adolescents necessitates the evaluation of current treatments. Family-based Treatment (FBT) is the standard treatment but has modest remission rates, highlighting the need for improvements. Assessing its effectiveness in adolescents with co-occurring mental health conditions is also crucial. In the Netherlands, there is a growing focus on home-based treatment. This study aims to enhance remission rates in FBT by adapting it for use in a home setting (FBT-H).

Eligibility

Sex
ALL
Min age
12 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * adolescents aged 12 to 18 years; * meeting the criteria for AN or other specified feeding or eating disorder (OSFED); * presence of co-occurring mental health conditions; * sufficient command of the Dutch language by adolescents and parents; * the family supports the treatment as a supportive system and is open to participating in the research. Exclusion Criteria: * acute suicidal behaviour requiring hospitalization within the 4 weeks prior to assessment for this study; * cognitive limitations (IQ \< 70); * participation of a sibling in the current study (to prevent transfer of therapy effects between siblings); * the adolescent does not receive tube feeding at the start of FBT-H and/or is not hospitalized due to an eating disorder at the start of treatment.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Karakter Almelo Overijssel

More Karakter Kinder- en Jeugdpsychiatrie trials in the Netherlands

Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design Recruiting
Psycho-education Program BLAME-LESS and It's Effect on Traumarelated Shame and Guilt Enrolling by invitation

Other trials for the same condition

Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes Active, not recruiting
Does Self-Efficacy at the Start of Treatment Influence Treatment Outcome in Patients With EDs? Recruiting
Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06792227 on ClinicalTrials.gov ↗ ← All trials in the Netherlands